{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:49:17Z","timestamp":1793342957042,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Norwegian Institute for Air Research, Kjeller, Norway"},{"name":"Oslo university  hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Quantitative measurements of cerebrospinal fluid to blood clearance has previously not been established for neurological diseases. Possibly, variability in cerebrospinal fluid clearance may affect the underlying disease process and may possibly be a source of under- or over-dosage of intrathecally administered drugs. The aim of this study was to characterize the cerebrospinal fluid to blood clearance of the intrathecally administered magnetic resonance imaging contrast agent gadobutrol (Gadovist, Bayer Pharma AG, GE). For this, we established a population pharmacokinetic model, hypothesizing that cerebrospinal fluid to blood clearance differs between cerebrospinal fluid diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Gadobutrol served as a surrogate tracer for extra-vascular pathways taken by several brain metabolites and drugs in cerebrospinal fluid. We estimated cerebrospinal fluid to blood clearance in patients with different cerebrospinal fluid disorders, i.e. symptomatic pineal and arachnoid cysts, as well as tentative spontaneous intracranial hypotension due to cerebrospinal fluid leakage, idiopathic intracranial hypertension, or different types of hydrocephalus (idiopathic normal pressure hydrocephalus, communicating- and non-communicating hydrocephalus). Individuals with no verified cerebrospinal fluid disturbance at clinical work-up were denoted references.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Population pharmacokinetic modelling based on 1,140 blood samples from 161 individuals revealed marked inter-individual variability in pharmacokinetic profiles, including differences in absorption half-life (time to 50% of tracer absorbed from cerebrospinal fluid to blood), time to maximum concentration in blood and the maximum concentration in blood as well as the area under the plasma concentration time curve from zero to infinity. In addition, the different disease categories of cerebrospinal fluid diseases demonstrated different profiles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present observations of considerable variation in cerebrospinal fluid to blood clearance between individuals in general and across neurological diseases, may suggest that defining cerebrospinal fluid to blood clearance can become a useful diagnostic adjunct for work-up of cerebrospinal fluid disorders. We also suggest that it may become useful for assessing clearance capacity of endogenous brain metabolites from cerebrospinal fluid, as well as measuring individual cerebrospinal fluid to blood clearance of intrathecal drugs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12987-022-00352-w","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T15:09:11Z","timestamp":1656688151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Population pharmacokinetic modeling of CSF to blood clearance: prospective tracer study of 161 patients under work-up for CSF disorders"],"prefix":"10.1186","volume":"19","author":[{"given":"Markus Herberg","family":"Hovd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen","family":"Mariussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Uggerud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aslan","family":"Lashkarivand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Ringstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Kristian","family":"Eide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"352_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137\u201347.","journal-title":"Ann Intern Med"},{"key":"352_CR2","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4:147ra111.","journal-title":"Sci Transl Med"},{"key":"352_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337\u201341.","journal-title":"Nature"},{"key":"352_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abb8739","volume":"370","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science. 2020;370:50\u20136.","journal-title":"Science"},{"key":"352_CR5","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1172\/JCI90603","volume":"127","author":"A Louveau","year":"2017","unstructured":"Louveau A, Plog BA, Antila S, Alitalo K, Nedergaard M, Kipnis J. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest. 2017;127:3210\u20139.","journal-title":"J Clin Invest"},{"key":"352_CR6","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1038\/s41467-020-18113-4","volume":"11","author":"AC Bolte","year":"2020","unstructured":"Bolte AC, Dutta AB, Hurt ME, Smirnov I, Kovacs MA, McKee CA, Ennerfelt HE, Shapiro D, Nguyen BH, Frost EL, et al. Meningeal lymphatic dysfunction exacerbates traumatic brain injury pathogenesis. Nat Commun. 2020;11:4524.","journal-title":"Nat Commun"},{"key":"352_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","volume":"577","author":"E Song","year":"2020","unstructured":"Song E, Mao T, Dong H, Boisserand LSB, Antila S, Bosenberg M, Alitalo K, Thomas JL, Iwasaki A. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours. Nature. 2020;577:689\u201394.","journal-title":"Nature"},{"key":"352_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41422-020-0287-8","volume":"30","author":"X Hu","year":"2020","unstructured":"Hu X, Deng Q, Ma L, Li Q, Chen Y, Liao Y, Zhou F, Zhang C, Shao L, Feng J, et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 2020;30:229\u201343.","journal-title":"Cell Res"},{"key":"352_CR9","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.1038\/s41598-019-51373-9","volume":"9","author":"Q Ma","year":"2019","unstructured":"Ma Q, Schlegel F, Bachmann SB, Schneider H, Decker Y, Rudin M, Weller M, Proulx ST, Detmar M. Lymphatic outflow of cerebrospinal fluid is reduced in glioma. Sci Rep. 2019;9:14815.","journal-title":"Sci Rep"},{"key":"352_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/0271678X18822921","volume":"40","author":"P Yanev","year":"2020","unstructured":"Yanev P, Poinsatte K, Hominick D, Khurana N, Zuurbier KR, Berndt M, Plautz EJ, Dellinger MT, Stowe AM. Impaired meningeal lymphatic vessel development worsens stroke outcome. J Cereb Blood Flow Metab. 2020;40:263\u201375.","journal-title":"J Cereb Blood Flow Metab"},{"key":"352_CR11","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1038\/s41467-020-16851-z","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Wang L, Xu H, Xing L, Zhuang Z, Zheng Y, Li X, Wang C, Chen S, Guo Z, et al. Meningeal lymphatics clear erythrocytes that arise from subarachnoid hemorrhage. Nat Commun. 2020;11:3159.","journal-title":"Nat Commun"},{"key":"352_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41586-021-03489-0","volume":"593","author":"S Da Mesquita","year":"2021","unstructured":"Da Mesquita S, Papadopoulos Z, Dykstra T, Brase L, Farias FG, Wall M, Jiang H, Kodira CD, de Lima KA, Herz J, et al. Meningeal lymphatics affect microglia responses and anti-A\u03b2 immunotherapy. Nature. 2021;593:255\u201360.","journal-title":"Nature"},{"key":"352_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41591-020-01198-1","volume":"27","author":"XB Ding","year":"2021","unstructured":"Ding XB, Wang XX, Xia DH, Liu H, Tian HY, Fu Y, Chen YK, Qin C, Wang JQ, Xiang Z, et al. Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson\u2019s disease. Nat Med. 2021;27:411\u20138.","journal-title":"Nat Med"},{"key":"352_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00702-012-0772-4","volume":"119","author":"RA Rissman","year":"2012","unstructured":"Rissman RA, Trojanowski JQ, Shaw LM, Aisen PS. Longitudinal plasma amyloid beta as a biomarker of Alzheimer\u2019s disease. J Neural Transm (Vienna). 2012;119:843\u201350.","journal-title":"J Neural Transm (Vienna)"},{"key":"352_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6:131\u201344.","journal-title":"Nat Rev Neurol"},{"key":"352_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","volume":"10","author":"W Chen","year":"2020","unstructured":"Chen W, Hu Y, Ju D. Gene therapy for neurodegenerative disorders: advances, insights and prospects. Acta Pharm Sin B. 2020;10:1347\u201359.","journal-title":"Acta Pharm Sin B"},{"key":"352_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00415-018-9124-0","volume":"266","author":"CD Wurster","year":"2019","unstructured":"Wurster CD, Winter B, Wollinsky K, Ludolph AC, Uzelac Z, Witzel S, Schocke M, Schneider R, Kocak T. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients. J Neurol. 2019;266:183\u201394.","journal-title":"J Neurol"},{"key":"352_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-019-1180-5","volume":"38","author":"GED Petrescu","year":"2019","unstructured":"Petrescu GED, Sabo AA, Torsin LI, Calin GA, Dragomir MP. MicroRNA based theranostics for brain cancer: basic principles. J Exp Clin Cancer Res. 2019;38:231.","journal-title":"J Exp Clin Cancer Res"},{"key":"352_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-019-0664-z","volume":"7","author":"S Jadhav","year":"2019","unstructured":"Jadhav S, Avila J, Sch\u00f6ll M, Kovacs GG, K\u00f6vari E, Skrabana R, Evans LD, Kontsekova E, Malawska B, de Silva R, et al. A walk through tau therapeutic strategies. Acta Neuropathol Commun. 2019;7:22.","journal-title":"Acta Neuropathol Commun"},{"key":"352_CR20","doi-asserted-by":"publisher","DOI":"10.3791\/60274","author":"Y Chen","year":"2019","unstructured":"Chen Y, Mazur C, Luo Y, Sun L, Zhang M, McCampbell A, Tomassy GS. Intrathecal delivery of antisense oligonucleotides in the rat central nervous system. J Vis Exp. 2019. https:\/\/doi.org\/10.3791\/60274.","journal-title":"J Vis Exp"},{"key":"352_CR21","first-page":"3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx J Am Soc Exp NeuroTher. 2005;2:3\u201314.","journal-title":"NeuroRx J Am Soc Exp NeuroTher"},{"key":"352_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.121537","volume":"3","author":"G Ringstad","year":"2018","unstructured":"Ringstad G, Valnes LM, Dale AM, Pripp AH, Vatnehol SS, Emblem KE, Mardal KA, Eide PK. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight. 2018;3:1\u201316.","journal-title":"JCI Insight"},{"key":"352_CR23","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1093\/brain\/awx191","volume":"140","author":"G Ringstad","year":"2017","unstructured":"Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain. 2017;140:2691\u2013705.","journal-title":"Brain"},{"key":"352_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-14195-x","volume":"11","author":"G Ringstad","year":"2020","unstructured":"Ringstad G, Eide PK. Cerebrospinal fluid tracer efflux to parasagittal dura in humans. Nat Commun. 2020;11:1\u20139.","journal-title":"Nat Commun"},{"issue":"4","key":"352_CR25","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/brain\/awab388","volume":"145","author":"G Ringstad","year":"2021","unstructured":"Ringstad G, Eide PK. Molecular trans-dural efflux to skull bone marrow in humans with cerebrospinal fluid disorders. Brain. 2021;145(4):1464\u201372.","journal-title":"Brain"},{"key":"352_CR26","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1038\/s41598-018-25666-4","volume":"8","author":"PK Eide","year":"2018","unstructured":"Eide PK, Vatnehol SAS, Emblem KE, Ringstad G. Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes. Sci Rep. 2018;8:7194.","journal-title":"Sci Rep"},{"key":"352_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.147063","volume":"6","author":"PK Eide","year":"2021","unstructured":"Eide PK, Mariussen E, Uggerud H, Pripp AH, Lashkarivand A, Hassel B, Christensen H, Hovd MH, Ringstad G. Clinical application of intrathecal gadobutrol for assessment of cerebrospinal fluid tracer clearance to blood. JCI insight. 2021;6:1\u201313.","journal-title":"JCI insight"},{"key":"352_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-019-0312-x","volume":"14","author":"TK Patel","year":"2019","unstructured":"Patel TK, Habimana-Griffin L, Gao X, Xu B, Achilefu S, Alitalo K, mckee CA, Sheehan PW, Musiek ES, Xiong C, et al. Dural lymphatics regulate clearance of extracellular tau from the CNS. Mol Neurodegener. 2019;14:11.","journal-title":"Mol Neurodegener"},{"key":"352_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1227\/01.NEU.0000363408.69856.B8","volume":"66","author":"PK Eide","year":"2010","unstructured":"Eide PK, Sorteberg W. Diagnostic intracranial pressure monitoring and surgical management in idiopathic normal pressure hydrocephalus: a 6-year review of 214 patients. Neurosurgery. 2010;66:80\u201391.","journal-title":"Neurosurgery"},{"key":"352_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.wneu.2015.09.067","volume":"86","author":"PK Eide","year":"2016","unstructured":"Eide PK, Sorteberg W. Outcome of surgery for idiopathic normal pressure hydrocephalus: role of preoperative static and pulsatile intracranial pressure. World Neurosurg. 2016;86:186\u201393.","journal-title":"World Neurosurg"},{"key":"352_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2176\/nmc.52.775","volume":"52","author":"E Mori","year":"2012","unstructured":"Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M, Nakajima M, Hashimoto M, Kuriyama N, Tokuda T, et al. Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir (Tokyo). 2012;52:775\u2013809.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"352_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","volume":"34","author":"MN Neely","year":"2012","unstructured":"Neely MN, van Guilder MG, Yamada WM, Schumitzky A, Jelliffe RW. Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R. Ther Drug Monit. 2012;34:467\u201376.","journal-title":"Ther Drug Monit"},{"key":"352_CR33","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/RLI.0b013e3181bfe2d2","volume":"44","author":"G Hahn","year":"2009","unstructured":"Hahn G, Sorge I, Gruhn B, Glutig K, Hirsch W, Bhargava R, Furtner J, Born M, Schr\u00f6der C, Ahlstr\u00f6m H, et al. Pharmacokinetics and safety of gadobutrol-enhanced magnetic resonance imaging in pediatric patients. Invest Radiol. 2009;44:776\u201383.","journal-title":"Invest Radiol"},{"key":"352_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/RLI.0000000000000204","volume":"51","author":"C Kunze","year":"2016","unstructured":"Kunze C, Mentzel HJ, Krishnamurthy R, Fleck R, Stenzel M, Bhargava R, Burrowes D, Sutter G, Schultze-Mosgau M, Santiuste M, Hahn G. Pharmacokinetics and safety of macrocyclic gadobutrol in children aged younger than 2 years including term newborns in comparison to older populations. Invest Radiol. 2016;51:50\u20137.","journal-title":"Invest Radiol"},{"key":"352_CR35","volume":"12","author":"A Verma","year":"2020","unstructured":"Verma A, Hesterman JY, Chazen JL, Holt R, Connolly P, Horky L, Vallabhajosula S, Mozley PD. Intrathecal (99m)Tc-DTPA imaging of molecular passage from lumbar cerebrospinal fluid to brain and periphery in humans. Alzheimers Dement (Amst). 2020;12: e12030.","journal-title":"Alzheimers Dement (Amst)"},{"key":"352_CR36","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2967\/jnumed.116.187211","volume":"58","author":"MJ de Leon","year":"2017","unstructured":"de Leon MJ, Li Y, Okamura N, Tsui WH, Saint-Louis LA, Glodzik L, Osorio RS, Fortea J, Butler T, Pirraglia E, et al. cerebrospinal fluid clearance in Alzheimer disease measured with dynamic PET. J Nucl Med. 2017;58:1471\u20136.","journal-title":"J Nucl Med"},{"key":"352_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12987-022-00318-y","volume":"19","author":"Y Li","year":"2022","unstructured":"Li Y, Rusinek H, Butler T, Glodzik L, Pirraglia E, Babich J, Mozley PD, Nehmeh S, Pahlajani S, Wang X, et al. Decreased CSF clearance and increased brain amyloid in Alzheimer\u2019s disease. Fluids Barriers CNS. 2022;19:21.","journal-title":"Fluids Barriers CNS"},{"key":"352_CR38","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.2967\/jnumed.117.190611","volume":"58","author":"JY Hesterman","year":"2017","unstructured":"Hesterman JY, Kost SD, Holt RW, Dobson H, Verma A, Mozley PD. Three-dimensional dosimetry for radiation safety estimates from intrathecal administration. J Nucl Med. 2017;58:1672\u20138.","journal-title":"J Nucl Med"},{"key":"352_CR39","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/0271678X18760974","volume":"39","author":"PK Eide","year":"2019","unstructured":"Eide PK, Ringstad G. Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: a glymphatic magnetic resonance imaging study. J Cereb Blood Flow Metab. 2019;39:1355\u201368.","journal-title":"J Cereb Blood Flow Metab"},{"key":"352_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/braincomms\/fcaa187","volume":"2","author":"PK Eide","year":"2020","unstructured":"Eide PK, Pripp AH, Ringstad G. Magnetic resonance imaging biomarkers of cerebrospinal fluid tracer dynamics in idiopathic normal pressure hydrocephalus. Brain Commun. 2020;2:1\u201316.","journal-title":"Brain Commun"},{"key":"352_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-72031-5","volume":"10","author":"E Melin","year":"2020","unstructured":"Melin E, Eide PK, Ringstad G. In vivo assessment of cerebrospinal fluid efflux to nasal mucosa in humans. Sci Rep. 2020;10:1\u201310.","journal-title":"Sci Rep"},{"key":"352_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1743-8454-7-9","volume":"7","author":"M Pollay","year":"2010","unstructured":"Pollay M. The function and structure of the cerebrospinal fluid outflow system. Cerebrospinal Fluid Res. 2010;7:9.","journal-title":"Cerebrospinal Fluid Res"},{"key":"352_CR43","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-019-12568-w","volume":"10","author":"L Jacob","year":"2019","unstructured":"Jacob L, Boisserand LSB, Geraldo LHM, de Brito NJ, Mathivet T, Antila S, Barka B, Xu Y, Thomas JM, Pestel J, et al. Anatomy and function of the vertebral column lymphatic network in mice. Nat Commun. 2019;10:4594.","journal-title":"Nat Commun"},{"key":"352_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1286-0115(05)83235-7","volume":"89","author":"RO Weller","year":"2005","unstructured":"Weller RO. Microscopic morphology and histology of the human meninges. Morphologie. 2005;89:22\u201334.","journal-title":"Morphologie"},{"key":"352_CR45","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41467-017-01484-6","volume":"8","author":"Q Ma","year":"2017","unstructured":"Ma Q, Ineichen BV, Detmar M, Proulx ST. Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice. Nat Commun. 2017;8:1434.","journal-title":"Nat Commun"},{"key":"352_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-8118-11-10","volume":"11","author":"T Brinker","year":"2014","unstructured":"Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS. 2014;11:10.","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"352_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/jmicro\/dfaa038","volume":"69","author":"O Kutomi","year":"2020","unstructured":"Kutomi O, Takeda S. Identification of lymphatic endothelium in cranial arachnoid granulation-like dural gap. Microscopy (Oxf). 2020;69(6):391\u2013400.","journal-title":"Microscopy (Oxf)"},{"key":"352_CR48","doi-asserted-by":"crossref","unstructured":"Ya\u011fmurlu K, Sokolowski J, Soldozy S, Norat P, \u00c7\u0131rak M, Tvrdik P, Shaffrey ME, Kalani MYS: A subset of arachnoid granulations in humans drain to the venous circulation via intradural lymphatic vascular channels. J Neurosurg 2021:1\u201310.","DOI":"10.3390\/brainsci10120953"},{"key":"352_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-25666-4","volume":"8","author":"PK Eide","year":"2018","unstructured":"Eide PK, Vatnehol SAS, Emblem KE, Ringstad G. Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes. Sci Rep. 2018;8:1\u201310.","journal-title":"Sci Rep"},{"key":"352_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00234-020-02519-4","volume":"63","author":"M Halvorsen","year":"2021","unstructured":"Halvorsen M, Edeklev CS, Fraser-Green J, Lovland G, Vatnehol SAS, Gjertsen O, Nedregaard B, Sletteberg R, Ringstad G, Eide PK. Off-label intrathecal use of gadobutrol: safety study and comparison of administration protocols. Neuroradiology. 2021;63:51\u201361.","journal-title":"Neuroradiology"},{"key":"352_CR51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.25670","volume":"87","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Cai J, Zhang W, Gong X, Yan S, Zhang K, Luo Z, Sun J, Jiang Q, Lou M. Impairment of the Glymphatic pathway and putative meningeal lymphatic vessels in the aging human. Ann Neurol. 2020;87:357\u201369.","journal-title":"Ann Neurol"},{"key":"352_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-019-0147-y","volume":"8","author":"W Zou","year":"2019","unstructured":"Zou W, Pu T, Feng W, Lu M, Zheng Y, Du R, Xiao M, Hu G. Blocking meningeal lymphatic drainage aggravates Parkinson\u2019s disease-like pathology in mice overexpressing mutated alpha-synuclein. Transl Neurodegeneration. 2019;8:7.","journal-title":"Transl Neurodegeneration"},{"key":"352_CR53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/bpa.12656","volume":"29","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang Y, Zhao Y, Marshall C, Wu T, Xiao M. Deep cervical lymph node ligation aggravates AD-like pathology of APP\/PS1 mice. Brain Pathol. 2019;29:176\u201392.","journal-title":"Brain Pathol"},{"key":"352_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita S, Louveau A, Vaccari A, Smirnov I, Cornelison RC, Kingsmore KM, Contarino C, Onengut-Gumuscu S, Farber E, Raper D, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature. 2018;560:185\u201391.","journal-title":"Nature"},{"key":"352_CR55","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296\u2013302.","journal-title":"Neuron"},{"key":"352_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D\u2019Orazio LM, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71\u20136.","journal-title":"Nature"},{"key":"352_CR57","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/jnen\/nlz063","volume":"78","author":"MM Hasan-Olive","year":"2019","unstructured":"Hasan-Olive MM, Hansson HA, Enger R, Nagelhus EA, Eide PK. Blood-brain barrier dysfunction in idiopathic intracranial hypertension. J Neuropathol Exp Neurol. 2019;78:808\u201318.","journal-title":"J Neuropathol Exp Neurol"},{"key":"352_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2019.146547","volume":"1727","author":"PK Eide","year":"2020","unstructured":"Eide PK, Hansson HA. Blood-brain barrier leakage of blood proteins in idiopathic normal pressure hydrocephalus. Brain Res. 2020;1727:1\u201313.","journal-title":"Brain Res"},{"key":"352_CR59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00004424-199407000-00008","volume":"29","author":"T Staks","year":"1994","unstructured":"Staks T, Schuhmann-Giampieri G, Frenzel T, Weinmann HJ, Lange L, Platzek J. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol. 1994;29:709\u201315.","journal-title":"Invest Radiol"},{"key":"352_CR60","first-page":"745","volume":"40","author":"RI Farb","year":"2019","unstructured":"Farb RI, Nicholson PJ, Peng PW, Massicotte EM, Lay C, Krings T, terBrugge KG. Spontaneous intracranial hypotension: a systematic imaging approach for CSF leak localization and management based on mri and digital subtraction myelography. AJNR Am J Neuroradiol. 2019;40:745\u201353.","journal-title":"AJNR Am J Neuroradiol"},{"key":"352_CR61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1227\/NEU.0b013e3182134399","volume":"69","author":"M Rahman","year":"2011","unstructured":"Rahman M, Bidari SS, Quisling RG, Friedman WA. Spontaneous intracranial hypotension: dilemmas in diagnosis. Neurosurgery. 2011;69:4\u201314 (discussion 14).","journal-title":"Neurosurgery"},{"key":"352_CR62","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1552-6569.2008.00270.x","volume":"19","author":"C Novotny","year":"2009","unstructured":"Novotny C, P\u00f6tzi C, Asenbaum S, Peloschek P, Suess E, Hoffmann M. SPECT\/CT fusion imaging in radionuclide cisternography for localization of liquor leakage sites. J Neuroimaging. 2009;19:227\u201334.","journal-title":"J Neuroimaging"},{"key":"352_CR63","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ana.24270","volume":"76","author":"KF Roberts","year":"2014","unstructured":"Roberts KF, Elbert DL, Kasten TP, Patterson BW, Sigurdson WC, Connors RE, Ovod V, Munsell LY, Mawuenyega KG, Miller-Thomas MM, et al. Amyloid-\u03b2 efflux from the central nervous system into the plasma. Ann Neurol. 2014;76:837\u201344.","journal-title":"Ann Neurol"},{"key":"352_CR64","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13195-020-00688-1","volume":"12","author":"W Feng","year":"2020","unstructured":"Feng W, Zhang Y, Wang Z, Xu H, Wu T, Marshall C, Gao J, Xiao M. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer\u2019s disease mouse model with suppression of glymphatic clearance. Alzheimer\u2019s Res Ther. 2020;12:125.","journal-title":"Alzheimer's Res Ther"},{"key":"352_CR65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-8118-8-7","volume":"8","author":"WM Pardridge","year":"2011","unstructured":"Pardridge WM. Drug transport in brain via the cerebrospinal fluid. Fluids Barriers CNS. 2011;8:7.","journal-title":"Fluids Barriers CNS"},{"key":"352_CR66","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129240","author":"C Mazur","year":"2019","unstructured":"Mazur C, Powers B, Zasadny K, Sullivan JM, Dimant H, Kamme F, Hesterman J, Matson J, Oestergaard M, Seaman M, et al. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.129240.","journal-title":"JCI Insight"},{"key":"352_CR67","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, Yamashita M, Rigo F, Hung G, Schneider E, et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet. 2016;388:3017\u201326.","journal-title":"Lancet"},{"key":"352_CR68","doi-asserted-by":"publisher","first-page":"4047617","DOI":"10.1155\/2019\/4047617","volume":"2019","author":"DM Byrnes","year":"2019","unstructured":"Byrnes DM, Vargas F, Dermarkarian C, Kahn R, Kwon D, Hurley J, Schatz JH. Complications of intrathecal chemotherapy in adults: single-institution experience in 109 consecutive patients. J Oncol. 2019;2019:4047617.","journal-title":"J Oncol"},{"key":"352_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.emc.2013.09.002","volume":"32","author":"Z Livshits","year":"2014","unstructured":"Livshits Z, Rao RB, Smith SW. An approach to chemotherapy-associated toxicity. Emerg Med Clin North Am. 2014;32:167\u2013203.","journal-title":"Emerg Med Clin North Am"},{"key":"352_CR70","doi-asserted-by":"publisher","first-page":"E2849","DOI":"10.1073\/pnas.1722344115","volume":"115","author":"AD Nguyen","year":"2018","unstructured":"Nguyen AD, Nguyen TA, Zhang J, Devireddy S, Zhou P, Karydas AM, Xu X, Miller BL, Rigo F, Ferguson SM, et al. Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay. Proc Natl Acad Sci U S A. 2018;115:E2849-e2858.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"352_CR71","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1172\/JCI99081","volume":"128","author":"A McCampbell","year":"2018","unstructured":"McCampbell A, Cole T, Wegener AJ, Tomassy GS, Setnicka A, Farley BJ, Schoch KM, Hoye ML, Shabsovich M, Sun L, et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Invest. 2018;128:3558\u201367.","journal-title":"J Clin Invest"},{"key":"352_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap8677","author":"C Niu","year":"2018","unstructured":"Niu C, Prakash TP, Kim A, Quach JL, Huryn LA, Yang Y, Lopez E, Jazayeri A, Hung G, Sopher BL, et al. Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7. Sci Transl Med. 2018. https:\/\/doi.org\/10.1126\/scitranslmed.aap8677.","journal-title":"Sci Transl Med"},{"key":"352_CR73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/14712598.2018.1416089","volume":"18","author":"N Hardcastle","year":"2018","unstructured":"Hardcastle N, Boulis NM, Federici T. AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials. Expert Opin Biol Ther. 2018;18:293\u2013307.","journal-title":"Expert Opin Biol Ther"},{"key":"352_CR74","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3174\/ajnr.A6136","volume":"40","author":"CS Edeklev","year":"2019","unstructured":"Edeklev CS, Halvorsen M, Lovland G, Vatnehol SAS, Gjertsen O, Nedregaard B, Sletteberg R, Ringstad G, Eide PK. Intrathecal use of gadobutrol for glymphatic MR imaging: prospective safety study of 100 patients. AJNR Am J Neuroradiol. 2019;40:1257\u201364.","journal-title":"AJNR Am J Neuroradiol"},{"key":"352_CR75","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191373","author":"M Patel","year":"2020","unstructured":"Patel M, Atyani A, Salameh JP, McInnes M, Chakraborty S. Safety of intrathecal administration of gadolinium-based contrast agents: a systematic review and meta-analysis. Radiology. 2020. https:\/\/doi.org\/10.1148\/radiol.2020191373.","journal-title":"Radiology"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00352-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-022-00352-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-022-00352-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T03:08:42Z","timestamp":1668481722000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-022-00352-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1186\/s12987-022-00352-w","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This present study was approved by The Regional Committee for Medical and Health Research Ethics (REK) of Health Region South-East, Norway (2015\/96), the Institutional Review Board of Oslo university hospital (2015\/1868), and the National Medicines Agency of Norway (15\/04932\u20137). Participants were included after providing written and oral informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Geir Ringstad received a fee for speaking at the Bayer symposium at the European Congress of Radiology 2020 (Vienna, Austria). Geir Ringstad and Per Kristian Eide also have a patent pending. The other authors disclose no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}